On thalidomide and WHO policies

Lepr Rev. 2003 Sep;74(3):288-90.
No abstract available

Publication types

  • Comment

MeSH terms

  • Abnormalities, Drug-Induced / prevention & control
  • Global Health
  • Health Policy*
  • Humans
  • Leprostatic Agents / adverse effects*
  • Leprosy / drug therapy*
  • Thalidomide / adverse effects*
  • World Health Organization

Substances

  • Leprostatic Agents
  • Thalidomide